Epstein Secrets

ve toots may rot babe aonnat laps muse 'mew tome report) Creatinine 0.62 LO BUN/Creat Ratio Cholesterol 210 HI Triglycerides HDL as % of 13 Chol/HDL Ratio Cholesterol MDC 35.2 HI Hemoglobin A1c 5.9 HI 33.9 HI ALT 42 HI 950 HI HDL CHOL., DIRECT 28 LO 7.5 NON FASTING CHEMISTRY -t"' - .syk'i

f the presence or absence of malignant disease. ASSAY INFORMATION: Method Electrochemiluminescence Immunoassay (Roche Diagnostics) PSA, FREE TNP Not Estab. ng/mL Test Not Performed: Specimen rejected for testing due to moderate or marked hemolysis. 0.70 101/27/2016 NOTE: Results cannot be interpre

10/27/2015 HDL CHOL., DIRECT 24 LO >40 mg/dL 29 LO 10/27/2015 HDL as % of Cholesterol 17 >14 % 14 * 10/27/2015 Evaluation: AVERAGE RISK Chol/HDL Ratio 6.0 <7.4 I 7.2 10/27/2015 Evaluation: AVERAGE RISK LDL/HDL Ratio Can't Calc <3.56 3.83 HI 10/27/2015 LDL Cholesterol Can't Calc <100 m

the presence or absence of malignant disease. ASSAY INFORMATION: Method Electrochemiluminescence Immunoassay (Roche Diagnostics) PSA, FREE 0.33 Not Estab. ng/mL I 0.31 10/27/201S BioReference Laboratories, Inc. Elmwood Park, NJ 07407 James Weisberger M.D. Page 3 of S Laboratory Director Prin

NEIL COL., DIRECT 28 LO >40 mg/dL 24 LO 01/27/2016 HDL as % of Cholesterol 13 Evaluation: ABOVE AV6.(MODERATE RISK) >14 X 17 01/27/2016 Chol/HDL Ratio 7.5 <7.4 6.0 01/27/2016 BioReference Laboratories, Inc. 481 Edward H. Ross Dr Elmwood Park, N7 07407 I (800) 2 9-5227 lames 4eisberger, Labo

th different assay methods or kits cannot be interchangeably. ASSAY INFORMATION: Method Electrocheedluninescence Immunoassay (Roche Diagnostics). Not Estab. ng/mi. to moderate or marked of the obtained used 1 0.33 101/27/2016 % FREE PSA TNP FREE PSA RISK ASSESSMENT The probability of prostate